Aptalis Pharma Canada ULC v. Par Pharmaceutical, Inc.

Application Number	Patent Number	External Links
-	US6350468	Espacenet Google Patents

COMPLAINT for PATENT INFRINGEMENT filed against Par Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2033068.) - filed by Forest Laboratories, LLC, Aptalis Pharma Canada ULC, Allergan USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmg) (Entered: 11/21/2016)

2016-11-18

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 11/21/2016)

2016-11-18

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/7/2016. Date of Expiration of Patent: 12/14/2018.Thirty Month Stay Deadline: 4/7/2019. (nmg) (Entered: 11/21/2016)

2016-11-18

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,350,468 B1. (nmg) (Entered: 11/21/2016)

2016-11-18

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC filed by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. (nmg) (Entered: 11/21/2016)

2016-11-18

1

View

Summons Issued with Magistrate Consent Notice attached as to Par Pharmaceutical, Inc. on 11/21/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg)

2016-11-18

1

No Actions

Summons Issued

2016-11-21

1

No Actions

Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb)

2016-11-23

1

No Actions

Case Assigned/Reassigned

2016-11-23

1

No Actions

REQUEST FOR WAIVER of Service sent to Par Pharmaceutical, Inc. on 2/1/2017 by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. Waiver of Service due by 3/3/2017. (Noreika, Maryellen) (Entered: 02/01/2017)

2017-02-01

1

View

WAIVER OF SERVICE returned executed by Forest Laboratories, LLC, Aptalis Pharma Canada ULC, Allergan USA, Inc.: For Par Pharmaceutical, Inc. waiver sent on 2/1/2017, answer due 4/3/2017. (Noreika, Maryellen) (Entered: 02/01/2017)

2017-02-01

1

View

STIPULATION TO EXTEND TIME to ANSWER Complaint to May 4, 2017 - filed by Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 03/29/2017)

2017-03-29

1

View

SO ORDERED, re 8 STIPULATION TO EXTEND TIME to ANSWER Complaint to May 4, 2017 filed by Par Pharmaceutical, Inc., Set/Reset Answer Deadlines: Par Pharmaceutical, Inc. answer due 5/4/2017. Signed by Judge Sue L. Robinson on 3/29/2017. (fms)

2017-03-29

1

No Actions

~Util - Set/Reset Answer Deadline AND SO ORDERED

2017-03-29

1

No Actions

STIPULATION of Dismissal by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. (Blumenfeld, Jack) (Entered: 04/18/2017)

2017-04-18

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,350,468 B1. (Attachments: # 1 Stipulation of dismissal)(nmfn) (Entered: 04/19/2017)

2017-04-19

1

View

SO ORDERED, re 9 Stipulation of Dismissal filed by Aptalis Pharma Canada ULC, Allergan USA, Inc., Forest Laboratories, LLC, (CASE CLOSED). Signed by Judge Sue L. Robinson on 4/19/2017. (nmfn)

2017-04-19

1

No Actions

~Util - Terminate Civil Case AND SO ORDERED

2017-04-19

1

No Actions

Overview

Parties

Defendant

Par Pharmaceutical, Inc.

Represented By

Plaintiff

Allergan USA, Inc.

Represented By

Forest Laboratories, LLC

Represented By

Aptalis Pharma Canada ULC

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 11/21/2016)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/7/2016. Date of Expiration of Patent: 12/14/2018.Thirty Month Stay Deadline: 4/7/2019. (nmg) (Entered: 11/21/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,350,468 B1. (nmg) (Entered: 11/21/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC filed by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. (nmg) (Entered: 11/21/2016)

Summons Issued with Magistrate Consent Notice attached as to Par Pharmaceutical, Inc. on 11/21/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg)

Summons Issued

Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb)

Case Assigned/Reassigned

REQUEST FOR WAIVER of Service sent to Par Pharmaceutical, Inc. on 2/1/2017 by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. Waiver of Service due by 3/3/2017. (Noreika, Maryellen) (Entered: 02/01/2017)

WAIVER OF SERVICE returned executed by Forest Laboratories, LLC, Aptalis Pharma Canada ULC, Allergan USA, Inc.: For Par Pharmaceutical, Inc. waiver sent on 2/1/2017, answer due 4/3/2017. (Noreika, Maryellen) (Entered: 02/01/2017)

STIPULATION TO EXTEND TIME to ANSWER Complaint to May 4, 2017 - filed by Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 03/29/2017)

SO ORDERED, re 8 STIPULATION TO EXTEND TIME to ANSWER Complaint to May 4, 2017 filed by Par Pharmaceutical, Inc., Set/Reset Answer Deadlines: Par Pharmaceutical, Inc. answer due 5/4/2017. Signed by Judge Sue L. Robinson on 3/29/2017. (fms)

~Util - Set/Reset Answer Deadline AND SO ORDERED

STIPULATION of Dismissal by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. (Blumenfeld, Jack) (Entered: 04/18/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,350,468 B1. (Attachments: # 1 Stipulation of dismissal)(nmfn) (Entered: 04/19/2017)

SO ORDERED, re 9 Stipulation of Dismissal filed by Aptalis Pharma Canada ULC, Allergan USA, Inc., Forest Laboratories, LLC, (CASE CLOSED). Signed by Judge Sue L. Robinson on 4/19/2017. (nmfn)

~Util - Terminate Civil Case AND SO ORDERED

Aptalis Pharma Canada ULC v. Par Pharmaceutical, Inc.

Overview

Parties

Defendant

Par Pharmaceutical, Inc. Follow

Represented By

Plaintiff

Allergan USA, Inc. Follow

Represented By

Forest Laboratories, LLC Follow

Represented By

Aptalis Pharma Canada ULC Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 11/21/2016)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/7/2016. Date of Expiration of Patent: 12/14/2018.Thirty Month Stay Deadline: 4/7/2019. (nmg) (Entered: 11/21/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,350,468 B1. (nmg) (Entered: 11/21/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC filed by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. (nmg) (Entered: 11/21/2016)

Summons Issued with Magistrate Consent Notice attached as to Par Pharmaceutical, Inc. on 11/21/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg)

Summons Issued

Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb)

Case Assigned/Reassigned

REQUEST FOR WAIVER of Service sent to Par Pharmaceutical, Inc. on 2/1/2017 by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. Waiver of Service due by 3/3/2017. (Noreika, Maryellen) (Entered: 02/01/2017)

WAIVER OF SERVICE returned executed by Forest Laboratories, LLC, Aptalis Pharma Canada ULC, Allergan USA, Inc.: For Par Pharmaceutical, Inc. waiver sent on 2/1/2017, answer due 4/3/2017. (Noreika, Maryellen) (Entered: 02/01/2017)

STIPULATION TO EXTEND TIME to ANSWER Complaint to May 4, 2017 - filed by Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 03/29/2017)

SO ORDERED, re 8 STIPULATION TO EXTEND TIME to ANSWER Complaint to May 4, 2017 filed by Par Pharmaceutical, Inc., Set/Reset Answer Deadlines: Par Pharmaceutical, Inc. answer due 5/4/2017. Signed by Judge Sue L. Robinson on 3/29/2017. (fms)

~Util - Set/Reset Answer Deadline AND SO ORDERED

STIPULATION of Dismissal by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. (Blumenfeld, Jack) (Entered: 04/18/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,350,468 B1. (Attachments: # 1 Stipulation of dismissal)(nmfn) (Entered: 04/19/2017)

SO ORDERED, re 9 Stipulation of Dismissal filed by Aptalis Pharma Canada ULC, Allergan USA, Inc., Forest Laboratories, LLC, (CASE CLOSED). Signed by Judge Sue L. Robinson on 4/19/2017. (nmfn)

~Util - Terminate Civil Case AND SO ORDERED

Track Case Updates

Par Pharmaceutical, Inc.

Allergan USA, Inc.

Forest Laboratories, LLC

Aptalis Pharma Canada ULC